Our Research Publications

Updated November 2023

Title Authors Year Sort ascending Journal Link to Article Intended Audience Purpose
Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells Evren S, Wan S, Ma XZ, Fahim S, Mody N, Sakac D, Jin T, Branch DR 2013 Genomics Researchers Basic research
Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cells Purohit MK, Scovell I, Neschadim A, Katsman Y, Branch DR, Kotra LP 2013 Bioorg Med Chem Lett Researchers Basic research
Ice recrystallization inhibitors: from biological antifreezes to small molecules Capicciotti CJ, Doshi M, Ben RN 2013 Recent developments in the study of recrystallization Researchers Basic research
Using simulation to evaluate a blood supply network in the Canadian maritime provinces Blake J, Hardy M 2013 J Enterp Inf Manag Researchers New or improved product or process
Approach to the diagnosis and management of drug-induced immune thrombocytopenia Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG 2013 Transfus Med Rev Health care providers Clinical research
Nonheparin anticoagulants for heparin-induced thrombocytopenia Kelton JG, Arnold DM, Bates SM 2013 N Engl J Med Health care providers Clinical research
ResearchUnit: What is the utility of selecting platelets by cross-matching? Shehata N 2013 Blood.ca website Other Other
Scanning the future of transfusion medicine Devine D, Dzik WH, Szczepiorkowski ZM 2013 Practical Transfusion Medicine, 4th edition Health care providers Other
The cellular pathophysiology of immune thrombocytopenia Semple JW 2013 ISBT Sci Ser Researchers Basic research
Thermal reversal of polyvalent choline phosphate, a multivalent universal biomembrane adhesive Yu X, Zou Y, Horte S, Janzen J, Kizhakkedathu JN, Brooks DE 2013 Biomacromolecules Researchers Basic research
An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death Gries CJ, White DB, Truog RD, Dubois J, Cosio CC, Dhanani S, Chan KM, Corris P, Dark J, Fulda G, Glazier AK, Higgins R, Love R, Mason DP, Nakagawa TA, Shapiro R, Shemie S, Tracy MF, Travaline JM, Valapour M, West L, Zaas D, Halpern SD, American Thoracic Society Health Policy Committee 2013 Am J Respir Crit Care Med Researchers Benchmarking and standard setting
Attitudes toward Reciprocity Systems for Organ Donation and Allocation for Transplantation Burkell JA, Chandler JA, Shemie SD 2013 J Health Polit Policy Law Researchers Other
Cellular immune dysfunction in immune thrombocytopenia (ITP) McKenzie CGJ, Guo L, Freedman J, Semple JW 2013 Br J Haematol Researchers Basic research
CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1 Marquez-Curtis LA, Gul-Uludag H, Xu P, Chen J, Janowska-Wieczorek A 2013 Cytotherapy Researchers Basic research
Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method Mastronardi C, Schubert P, Levin E, Bhakta V, Yi QL, Hansen A, Stewart T, Jenkins C, Lefresne W, Sheffield W, Acker JP 2013 J Blood Transfus Blood operators New or improved product or process
A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, Warkentin TE, Kelton JG 2013 J Thromb Haemost Health care providers Clinical research
Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J 2013 Vox Sang Regulators New or improved product or process
Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J 2013 Transfusion Regulators New or improved product or process
FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia Nazi I, Arnold DM, Smith JW, Horsewood P, Moore JC, Warkentin TE, Crowther MA, Kelton JG 2013 J Thromb Haemost Researchers Basic research
Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions Hansen A, Yi QL, Acker JP 2013 Transfusion Researchers New or improved product or process
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H 2013 Thromb Haemost Researchers Basic research
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ, PROTECT Investigators on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Clinical Trials Group 2013 Thromb Res Researchers Clinical research
Challenges in the management of the blood supply Williamson LM, Devine DV 2013 Lancet Blood operators Other
Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition Roddick LA, Bhakta V, Sheffield W 2013 BMC Biochem Researchers Basic research
Legal Aspects of the Blood System in Canada Reis NM 2013 Public Health Law and Policy in Canada Other Other
A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada Fearon MA, Scalia V, Huang M, Dines I, Ndao M 2013 Can J Infect Dis Med Microbiol Health care providers Clinical research
Positioning new treatments in the management of immune thrombocytopenia Arnold DM 2013 Pediatr Blood Cancer Researchers Clinical research
Research with Blood Donated to Blood Banking Organizations Reis NM 2013 Health Law Review Other Other
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators 2013 Transfusion Researchers Clinical research
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway Crow AR, Yu H, Han D, Lazarus AH 2013 PLoS One Researchers Basic research
Donor hemovigilance Goldman M 2013 Blood Transfus Health care providers Other
Expert approaches to common bleeding and thrombotic problems, part II Hayward CP, Webert KE 2013 Semin Thromb Hemost Health care providers Other
The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP 2013 BMC Biochem Researchers Basic research
A platelet cover-up Arnold DM 2013 Blood Researchers Other
Legal Foundations of Public Health Law Reis NM 2013 Public Health Law and Policy in Canada Other Other
Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles Bicalho B, Holovati JL, Acker JP 2013 Biochim Biophys Acta Researchers Basic research
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV 2013 Transfusion Researchers Basic research
Alloimmunization of patients by blood units harboring distinct DEL variants St-Louis M, Lebrun A, Goldman M, Lavoie M 2013 Immunohematology Health care providers Clinical research
Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H 2013 Cardiovasc Hematol Disord Drug Targets Researchers Other
Identifying D-positive donors using a second automated testing platform Goldman M, Resz I, Cote J, Ochoa G, Angus N 2013 Immunohematology Blood operators New or improved product or process
ResearchUnit: Should patients receive HLA-selected platelets? Shehata N 2013 Blood.ca website Other Other
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P 2013 Transfusion Health care providers Benchmarking and standard setting
CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide Kim M, Binnington B, Sakac D, Lingwood CA, Branch DR 2013 AIDS Researchers Basic research
Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues Trant JF, Briggs RA, Capicciotti C, Ben RN 2013 RSC Adv Researchers Basic research
ResearchUnit: Doubling the 30-minute rule without compromising Red Blood Cells quality and safety. Ramirez-Arcos S 2013 Blood.ca website Other Other
Thrombocytopenia in the critically ill Shehata N, Fontes ML 2013 Can J Anaesth Researchers Other
Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain Kurbegovic A, Trudel M 2013 Hum Mol Genet Researchers Basic research
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists Ghadaki B, Nazi I, Kelton JG, Arnold DM 2013 Transfusion Health care providers Clinical research
Unraveling the IVIG mystique Branch DR 2013 Transfusion Researchers Other
What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers Lane S, Arnold E, Webert KE, Chan A, Walker I, Heddle NM 2013 Haemophilia Health care providers Other